Austin Exploration welcomes new cornerstone investor

THE ROADHOUSE BOWSER: Austin Exploration (ASX: AKK) has welcomed UK-based institutional investor Lanstead Capital L.P. as a cornerstone investor in the company.

Austin said Lanstead’s new standing had come via a 19.8 per cent equity investment into the company.

Lanstead declared its long term-support for Austin by agreeing to hold the stock for a minimum of two years, which Austin said would provide stability to the company register.

Austin explained the deal places restrictions on Austin pursuing and executing other equity and debt funding initiatives.

Lanstead will invest $4.513 million into Austin by way of a subscription for 59 million new ordinary shares a price of 7.65 cents per share.

Austin indicated the proceeds raised will enable the company to continue its high-impact, low capital cost drilling program throughout its North American properties, including its ongoing participation in the Eagle Ford drilling campaign currently underway in Texas.

Drilling operations are currently being completed at the company’s sixth well, the Seaducer 1A well, and drilling of a seventh well is scheduled to commence in coming weeks.

In November, Austin declared itself to be cash flow positive on the back of its Eagle Ford well development program in Texas and its other business units which has led to growth in oil and gas production in 2014.

“We are very pleased to have secured Lanstead as our first cornerstone investor,” Austin Exploration chief executive officer and managing director Mark Hart said in the company’s announcement to the Australian Securities Exchange.

“We have a very busy six months ahead of us with our drilling program in the United States, and we now have the financial flexibility to strengthen our well development program.

“We have worked diligently with Lanstead to structure a finance package that meets our upcoming drilling commitments and allows for additional funding and growth to occur as we bring more wells on-line and substantially ramp up production.”

Biotron completes recruitment for Phase 2 Hepatitis C trial

THE ROADHOUSE PHARMACY: Biotron Limited (ASX: BIT) has completed patient enrolment for a Phase 2 trial, which will evaluate lead compound BIT225 as a potential new therapy for the treatment of Hepatitis C virus (HCV) infection.

A total of 60 patients infected with HCV genotypes 1 or 3 (G1, G3) has been recruited at six established trial sites in Thailand for the randomised, placebo controlled three-month dosing study (Protocol BIT225-008).

Biotron said the trial has been designed to extend efficacy data against HCV G1 and G3, and to provide further confirmation of BIT225’s safety and tolerability profile in longer term dosing using the new capsule formulation of the drug.

The study extends the company’s previous study, which produced data was based on four week dosing regimes.

“It is important we provide further safety and efficacy data that demonstrates further safety and tolerability over 12 weeks,” Biotron Limited managing director Dr Michelle Miller said in the company’s announcement to the Australian Securities Exchange.

“If successfully developed, BIT225 will most likely be used in combination with other new classes of direct-acting antiviral (DAA) drugs, which currently require a minimum dosing period of 12 weeks.

“Safety and antiviral efficacy data to date has been extremely encouraging and we are confident this will be replicated in an extended dosing regime.”

Under trial protocols, patients are receiving 200 mg of BIT225 twice daily for three months in combination with current standard of care therapies – pegylated interferon alfa 2b (IFN) and ribavirin (RBV) before continuing to receive standard of care out to 24 weeks (genotype 3) or 48 weeks (genotype 1).

A previous Phase 2a study demonstrated that 100 per cent of HIV G1 patients who received BIT225 (400 mg) over four weeks in conjunction with standard of care therapies had undetectable levels of virus at the 48 week follow up.

This was compared to 75 per cent of patients who received standard of care alone.

BIT225 also showed good efficacy in a Phase 2 trial of BIT225/IFN/RBV in patients co-infected with HIV and HCV G3, with all patients who completed treatment having undetectable levels of HCV 12 weeks after ceasing all treatment, which Biotron said is an indication that they were cured of HCV infection.

“Despite recent advances in treatment of HCV, significant treatment gaps remain, in particular for genotype 3,” Dr Miller said.

“We look forward to progressing commercialisation of BIT225 as a valuable new therapy that will work in combination with current and future treatment strategies.”

Website: www.biotron.com.au

Anatolia encounters new uranium at Sefaatli

Anatolia Energy (ASX: AEK) has completed a further at the Tulum Tepe and Deliler prospects within the company’s Sefaatli uranium project.

Anatolia said all holes had intersected uranium mineralisation while also encountering further mineralisation in the vicinity of a recently-identified cross-cutting fault at the Deliler prospect.

The company claims the drilling at the Tulu Tepe prospect has discovered new mineralisation with two holes returning:

2.5 metres at 2150ppm uranium from 81.7m, including 1.2m at 3980ppm uranium (SD60); and

4.3m at 930ppm uranium from 80.3m, including 0.5m at 2240ppm uranium (SD69).

Drilling within the vicinity of the cross-cutting fault at Deliler returned:

1.8m at 940ppm uranium from 74.4m, including 0.6m at 1940ppm uranium (SD62); and

1.3m at 580ppm uranium from 51.9m, including 0.5m at 1520ppm uranium (SD67).

“These recent results indicate strong mineralisation within the Sefaatli project exceeding our expectations,” Anatolia Energy interim CEO and managing director Paul Cronin said in the company’s announcement to the Australian Securities Exchange.

“It is increasingly likely that Sefaatli may be capable of being developed as a satellite operation to feed into our advanced Temrezli ISR uranium project.

“The discovery of the fault zone within the Deliler prospect and the new uranium mineralisation at Tulu Tepe are very encouraging and gives us all necessary confidence to plan the Phase 2 drilling likely to commence in Q1 2015.”

Email: admin@anatoliaenergy.com.au

Website: www.anatoliaenergy.com.au

 

Quest Petroleum to JV Alberta oil sands project

THE ROADHOUSE BOWSER: Quest Petroleum (ASX: QPN) has executed a binding Terms Sheet with Keyano Pimee Exploration Company Limited (KPECL) – a First Nations company – for a phased farm-in to develop acreage with verified oil shows located in the Cold Lake oil sands region of Alberta, Canada.

KPECL is a company owned by the indigenous Saddle Lake and the Whitefish Lake Cree Nations and is currently involved in long standing gas production in the Cold Lake region, 200 kilometres north-east of Edmonton.

According to Quest the KPECL lands are currently producing approximately 2 million cubic feet (mmcf) of gas per day from 23 existing wells.

KPECL has an 82,290 acre land holding (with the associated ownership of the underlying minerals) under its control and plans to transition from a gas royalty company to an active oil producer through the proposed joint arrangement with Quest.

In Phase 1, Quest has committed to an initial four well re-entry program in areas where oil occurrences have been encountered during gas production activities on the KPECL lands.

The combined all-in cost of these four re-entries is estimated at US$700,000.

On completion of the Phase 1 program, Quest will earn a 50 per cent interest in the four wells and four corresponding 640 acre sections of project land and the right to proceed with Phase 2 of the farm-in.

Phase 2 involves Quest funding thirteen low cost (estimated to be US$600,000 each) vertical conventional wells or additional re-entries to test oil occurrences across thirteen separate 640 acre project sections, earning the company a 50 per cent interest in the wells and the thirteen corresponding sections of land as well as the right to proceed to Phase 3 of the project.

Quest is also entitled to recover all of its Phase 1 and 2 costs from 80 per cent of the production revenue.

Phase 3 consists of drilling vertical and horizontal wells on a 50:50 working interest basis with KPECL across the remaining project area.

During Phase 3, KPECL and Quest will jointly fund an ongoing program where each successful vertical well will serve as the pad for the drilling of up to twelve horizontal production wells per section to recover oil from various oil sand horizon(s) using the in-situ cold oil production with sand (CHOPS) method.

Quest explained CHOPS is a technique for extracting heavier crude oil where sand is used as a means enhancing the productivity of the oil well.

“We are pleased to partner with KPECL and the Cree First Nations people in the development of this extensive near term production opportunity in this highly prospective location,” Quest Petroleum managing director Anthony Milewski said in the company’s announcement to the Australian Securities Exchange.

“We see this as the first step in a significant production orientated focus for the company in both Alberta and the prolific Cold Lake region and a long term partnership with KPECL.”

Email: info@qpnl.com.au

Website: www.qpnl.com.au

Starpharma gets New Zealand marketing clearance for VivaGel condom

THE ROADHOUSE PHARMACY: Starpharma Holdings (ASX: SPL) has completed regulatory requirements to allow for marketing of the VivaGel® condom in New Zealand under the brand Lifestyles® Dual Protect™.

Starpharma’s commercial partner, Ansell, along with its New Zealand distributor, EBOS Group, plan to launch the Lifestyles Dual Protect condom in the New Year having obtained market clearance for New Zealand.

Dual Protect with VivaGel is the world’s first antiviral condom.

“We are very pleased to announce this next approval of the VivaGel condom for marketing, and look forward to further regulatory acceptances and launches of the product in other regions in the future,” Starpharma Holdings CEO Dr Jackie Fairley said in the company’s announcement to the Australian Securities Exchange.

Website: www.starpharma.com

Brain Resource strikes MyBrainSolutions deal with NRMA

THE ROADHOUSE PHARMACY: Brain Resource Limited (ASX: BRC) has reached an agreement with National Roads and Motorists’ Association Limited (NRMA) to offer the company’s MyBrainSolutions to NRMA members through its Living Well Navigator portal.

“NRMA’s Living Well Navigator is an online resource and social community available to like-minded people who share common attitudes and interests,” Brain Resource said in its ASX announcement.

“It aims to help Members make more informed decisions and live independently for longer as they get older.”

Brain Resource explained MyBrainSolutions is being included on Living Well Navigator to provide NRMA members with resources that promote Brain Health, a critical component of overall health.

The company described MyBrainSolutions to be an integrated online platform for Brain Health that allows a user to build brain health, resilience and to manage stress.

It comprises an assessment to allow users to identify their individual strengths and limitations, exercises to train the brain, and monitor progress.

The deal with NRMA is to start with a three month trial, to be followed by a broad offering based on a successful completion of the trial.

NRMA members are to be provided with full access to MyBrainSolutions during this pilot, commencing early in 2015.

Brain Resource and NRMA flagged their intent to move to a paid offer post completion of this initial offer should the pilot prove successful and commercial terms be agreed.

MyBrainSolutions is predominantly currently sold in the United States market to corporations, with clients including those in the Fortune 500 such as Cisco, Facebook, Aetna, and Nationwide.

Email: investor@brainresource.com

Website: www.brainresource.com

Fund Raising across the Boards

THE FUND RAISER: There seems to be enough going on to suggest interest in the resources sector still exists.

$600,000 Equity Raising

Enterprise Metals (ASX: ENT) is targeting an equity raising of $400,000 through a planned private equity placement to its largest shareholder Sinotech Minerals and a number of sophisticated investors, plus an accompanying Share Purchase Plan (SPP) to all shareholders targeting an additional $200,000 in equity funding.

SinoTech has indicated its intent to subscribe for $100,000 (25 per cent) of the private equity placement tranche.

The funds will advance exploration on the company’s Fraser Range nickel sulphide target.

“Enterprise has some of the most prospective ground in the Fraser Range for nickel-copper massive sulphides, centred along the gravity ridge containing a major layered mafic complex, and our target testing phase has only just begun,” Enterprise Metals managing director Dermot Ryan said.

Both the private placement and SPP are priced at four cents per share


$8.5 million non-renounceable Rights Issue Offer

Xanadu Mines (ASX: XAM) announced terms of a rights issue it will undertake immediately following the anticipated approval of a $13.6 million placement at the company’s AGM on 28 November 2014.

The company proposes a non-renounceable rights issue to eligible shareholders, on the basis of two new fully paid ordinary shares for every seven shares held, at an issue price of 12.26 cents per share to raise up to $8.5 million.

The funds raised under the Rights Issue (after payment of costs) will be used to partly repay the deferred consideration for the Kharmagtai project and advance exploration activities at the Kharmagtai and Oyut Ulaan copper-gold projects.


$3 Million Funding Agreement

Citigold Corporation (ASX: CTO) has agreed to a $3 million debt facility to assist in further advancing the company’s high-grade 100 per cent-controlled Charters Towers gold project.

The loan facility has nil interest rate and is fully drawn at the start by the issue of 30,000 notes of $100 each, which are not convertible into shares.

Citigold can redeem the notes at any time at a redemption cost of $110 per note if within six months, and a cost of $120 per note if between six and 12 months.

The notes are secured by mortgages over some of the mining leases and other tenure controlled by Citigold as well as the process plant.

The note facility is with CGN Finance Pty Ltd and was brokered between Citigold and CGN by 1P Capital out of Sydney.


Non-Renounceable Rights Issue

Platypus Minerals (ASX: PLP) is undertaking a non-renounceable rights issue to raise up to approximately $1.6 million.

Net proceeds in conjunction with existing cash reserves will be used to advance exploration on the company’s Australian and Peruvian exploration projects, repay debt and for general working capital.

New shares will be offered on the basis of one new share for each two shares held with a price of 2 cents per new share with one free attaching option exercisable at 3.5 cents on or before 1 December 2016 for every two new shares.

Platypus Minerals director Rick Crabb has agreed to underwrite the offer for up to $235,000, with $185,000 to be set off against loans to Platypus by Crabb.


Pro-Rata Non-Renounceable Rights Issue

Australia United Mining (ASX: AYM) announced a pro-rata non-renounceable rights issue to eligible shareholders, on the basis of one new share for every three shares held.

The company will issue up to approx. 22.3 million fully paid ordinary shares in the capital of the company at an issue price of 1 cent each, to raise approximately $2.23 million (before costs).

What the Analysts Say

WHAT THE ANALYSTS SAY: Interesting news and views from across the Resource Analyst universe.

Website: www.beerandco.com.au

Company: Diatreme Resources (ASX: DRX)

In March 2012, Diatreme announced the results of its Pre‐Feasibility Study on the Cyclone mineral sands deposit, with a pay‐back period of 2.1years.

While DRX had announced, in August 2010, a MoU with the largest end user of zircon in China, there were four key assurances required, and three have now been delivered, with the final, environmental clearance for an access road, now in train.

Diatreme is now re‐engaging with potential off‐take partners and financiers.

A formal commitment to project construction can be expected late in 2015, with first product in early 2017.

Three of the four required assurances now delivered

In 2013, DRX advised that to execute the Memorandum of Understanding into a binding Heads of Agreement, four key issues needed to be resolved:

Water supply was located in November 2013, with the successful drilling of a water bore within the area of the Exploration Lease;

The signing of a Native Title Agreement was announced on 17 November 2014;

A Mining Licence, which was announced on 24 November 2014; and

Approval for a road transport corridor from Cyclone to the rail line at Forrest, for which the Public Environmental review documents have been lodged.

In short, DRX is now making real progress on the Cyclone project.

Cyclone Valuation

On 9 January 2014, DRX announced a Heads of Agreement with Perpetual Mining Holdings Limited (PMHL), a Hong Kong-based company with sound business connections within China including in iron ore mining and steel products processing, for PMHL to acquire a 6 per cent stake in the Cyclone project for $2 million.

Beer & Co expects zircon prices to firm to US$1,500 per tonne, and rutile to US$1,250 per tonne by 2017, when Cyclone begins production.

Our resulting, after‐tax valuation of Cyclone is $125 million.

Financing

Estimated capital to get into production is $146 million.

Beer & Co expects that DRX’s current discussions with potential investors and off‐take partners results in a party buying a project stake at a value related to NPV, and the new party facilitates the required capital.

Website: www.breakawayresearch.com

Company:  Thundelarra Limited (ASX: THX)

Recent drilling at the Red Bore prospect has intersected exceptionally high grade primary copper, confirming the potential of the prospect.

Ongoing work, including a reinterpretation of the mineralisation, ground magnetics and drill results has resulted in a number of other copper-gold targets being identified within the Red Bore and Curara Well leases, which now require further drill testing, which is expected to commence soon.

Ongoing work at the Pine Creek project has delineated a number of prospects that are now being drilled.

Previous work has resulted in a number of very encouraging drill intersections for a range of metals, including copper, gold, uranium and tungsten.

Thundelarra Limited (ASX: THX) has a portfolio of advanced exploration properties, with the flagship being the Doolgunna project, located adjacent to Sandfire’s (ASX: SFR) DeGrussa volcanic-hosted massive sulphide (VHMS) copper-gold operation, which has a current resource of 13.4 million tonnes at 4.7 per cent copper and 1.9 grams per tonne gold.

Recent work by the company has been concentrated at Doolgunna, and in particular the Red Bore prospect, with shallow high grade copper being intersected in diamond and reverse circulation drilling, which will potentially expand the current modest resource of 48,000 tonnes at 3.6 per cent copper and 0.4g/t gold.

The company is also actively exploring its Pine Creek project, with this area, located over the Pine Creek Orogen in the Northern Territory, being prospective for a range of base and precious metals, as well as uranium, for which a resource of 1.4 million tonnes at 304ppm uranium has been defined, and which is still open.

Lower priority holdings include the uranium prospective Ngalia Basin project and a number of tenements in the East Kimberley region of Western Australia.


Disclaimer: The above is intended as a guide only. The Roadhouse accepts no responsibility for investments made from this advice, successful or otherwise.

The views, opinions or recommendations of this article do not in any way reflect the views, opinions, recommendations, of The Resources Roadhouse.

The Roadhouse makes no representation or warranty with respect to the accuracy, completeness or currency of the content. The content is for educational purposes only and does not constitute financial advice. Independent advice should be obtained from an Australian financial services licensee before making investment decisions.

Friday Flashback

THE WEEKLY WRAP: the market gave nobody anything to celebrate last Friday closing 10 points down to record its worth weekly performance for more than a year.

As bad as that was, the week ended a lot worse for our PM, Tony Abbott with a report from the United Nations Environment Program listing Australia as one of four countries not on course to meet their emissions reduction promises.

According to the report Australia, Canada, Mexico, and the United States all need to stand in front of a big mirror and take a good hard look at themselves in the carbon heavy lifting department if they were to meet their respective emissions targets by 2020.

Abbot’s call of coal being ‘good for humanity’ was also taken to task by Andrew Steer, president of US development research organisation World Resources Institute, who said Australia was wrong to view fossil fuels as the way to boost economic growth.

On Monday, China sneezed and everybody felt better with the People’s Bank of our brand new trading partner cutting interest rates for the first time in more than two years.

Even the brief drop of the iron ore price charting into sub-US$70 per tonne territory failed to hold back the happy wave of investor sentiment as all sectors enjoyed a buoyant day, except for the Telcos and the way my Vodafone connectivity behaves I’m happy for that particular status qui to remain for as long as possible.

Not all good news for everybody however, with the ABC cuts starting to kick in and redundancies to be handed out.

As try as it might, the Medibank private listing on Tuesday failed to resuscitate the market, which spent another day in the doldrums.

The much-anticipated health fund debut didn’t really set off any fireworks, coming on at $2.22 and easing back through the day to its first close at $2.14.

Although the iron ore price ended the day above the $US70 psychological barrier there is still real concern it will slip further.

BHP Billiton (ASX: BHP) was 80 cents short for the day at $32.10, Rio Tinto (ASX: RIO) lost 89 cents to $57.25, and Fortescue Metals dropped 17 cents to $2.81.

The Medibank bubble lost some air on Wednesday closing at $2.09 – below the $2.15 institutions paid.

Doubtful they’ll be too disappointed give they can now buy more at a discounted price, and in reality they’re probably the only buyers out there at the moment.

That didn’t stop the share market enjoying its best day since August with gains across the boards.

The iron ore price continued its slide to take up residence in the US$60 range marking a five-year low.

Yesterday the market just managed to keep its nose above water.

The iron ore price is now officially in free-fall as it hit another new five-year low close to $US68 a tonne.

This time the mining giants were unable to dodge the bullet with BHP Billiton losing 53 cents to $32.00 and Rio Tinto dropping 37 cents to $58.02.

Just to prove there is no exact science involved Fortescue Metals gained seven cents to close at $2.86.

Oil prices dropped to $US77.66 a barrel to hit energy stocks, but failed to register any impact at our local petrol station which jumped to $1.42 a litre from $1.28 just the night before – work that out!

 

Commodity Bright Spots

GAVIN WENDT: Whilst the media is almost exclusively full of doom-and-gloom stories as far as commodities are currently concerned, the reality is somewhat different.

For example, the recent pullback in the price of silver to four-and-a half-year lows has led to a surge in investor interest, with the United States Mint this week running out of American Eagle silver coins due to ‘tremendous’ demand.

We’re yet to see the same level of bargain buying interest in gold, but it won’t be far off.

At the same time, gold’s supply side is set to take a big hit if gold prices remain around current levels, with most of the world’s gold producers using gold price assumptions of $1,300 in their reserves calculations.

Sustained price weakness will therefore lead to a major rebalance in the gold industry’s fundamentals.

Irrespective, the US dollar will likely peak during 2015 and gold will recover as economic growth outside of the US also recovers.

With respect to other metals, zinc and nickel remain the best bets.

Silver Scramble

The recent weakness in silver prices to four-and-a-half-year lows has triggered a global scramble by consumers to purchase silver coins and bars, with the metal reaching its cheapest level versus gold in more than five years.

In fact the US Mint has temporarily sold out of its American Eagle silver bullion coins after recent ‘tremendous’ demand.

 

Silver demand has been robust over the past few months, but retailers say buying interest has soared over recent weeks as the price weakened and bargain hunters stepped into the market.

Silver has fallen to lows of around $15 per ounce, which represents a 21 per cent yearly decline.

An ounce of gold is now approximately equal in price to 74 ounces of silver, the biggest spread between the metals since early 2009.

Due to its greater affordability, silver sales tend to outstrip gold in volume terms and attract a lot more retail buyers, a situation that’s likely to continue for the foreseeable future.

Looming Gold Reserve Write-Downs

One of the interesting bits of data that I’ve recently come across that supports my belief in a near-term floor for gold prices, relates to the assumed gold prices on which most major gold companies throughout the world have based their reserve cut-offs.

If gold stays where it is (below US$1,200 per ounce) then gold companies won’t just be facing a likely profit hit – they’ll also be taking a massive hit on their gold reserves positions, which in turn will lead to substantial balance sheet write-downs.

TD Securities has provided a research note examining the various gold price assumptions of some of the major North and South American producers.

 

The table demonstrates the likelihood of significant reserve write-downs amongst major producers like Goldcorp, Newmont and New Gold (all with $1,300 price assumptions), B2Gold with one of the highest price assumptions at $1,350, along with Eldorado with pricing between $1,000 to $1,250 and lamgold with pricing between $1,100 and $1,400.

Companies where write-downs are likely to be minimal include Yamana (with price assumptions between $900 and $950).

Miners typically recalculate reserves at year’s end, so be prepared for substantial write-downs during the course of early 2015 if prices stay where they are.

Mixed Signals for 2015 Global Growth

There was a very interesting presentation given by CIBC Senior Economist World Markets, Peter Buchanan, at the recent MineLatinAmerica symposium in Toronto.

He believes the US recovery will continue to advance, supporting the uptake and price of various commodities into 2015.

Interestingly, even gold could expect a brighter outlook next year.

The general belief is that the market jitters of mid-October have faded somewhat, as evidence of the US’s recovery continued to build.

GDP growth rates were positive during the third quarter, with an advanced estimate of 3.5 per cent announced by the US Department of Commerce, which followed the second quarter’s robust 4.6 per cent growth rate.

In the future, the US could expect a rate of just below 3 per cent for 2015 and 2.5 per cent for 2016.

An important facet of the recovery had apparently been the increase in motor vehicle sales, spurred by drivers replacing their older vehicles.

This purchasing is forecast to continue, which would in turn help buoy the consumption of several metals.

Meanwhile, pent-up demand for housing would help boost property purchases, in turn providing additional support for industrial metals.

The Eurozone’s growth levels were likely to be below 2 per cent in both 2015 and 2016, with figures for Eastern Europe decelerating, weighed on by Russia’s economic performance following the imposition of sanctions.

With respect to South America, the growth performance was mixed.

CIBC noted 2 per cent growth continent-wide, with Chile and Peru the strongest performers, whilst Brazil, Argentina and Venezuela would continue to face difficulties.

On an encouraging note however, China’s GDP growth rate remained strong, despite dipping to 7.3 per cent for the third quarter, down slightly from the government’s objective of 7.5 per cent.

Stimulus measures were likely however to boost China’s fourth-quarter growth figure up to the 7.5 per cent target.

CIBC then expects growth to slow to 7 per cent in 2015 and to 6.8 per cent in 2016.

The forecast decline however obscures the incremental increase in China’s increased consumption of commodities, which even at the lower growth levels, still represents twice the level of demand ten years ago.

Commodity Outlook

Of all the commodities, zinc’s fortunes look most positive, with London Metals Exchange inventories declining once again.

Further support was likely from mine closures next year and an increase in uptake for galvanizing purposes.

Almost half of zinc demand relates to galvanizing and there is likely to be strong support coming from the US construction and automotive sectors, with average prices of $110 per pound in 2015 and $125 per pound during 2016.

With respect to nickel, the Indonesian ban on nickel ore exports is expected to be felt into 2015, with $8 per pound during 2015 and even stronger in 2016.

Copper meanwhile has advanced back to $3 per pound, whilst inventories appeared to have bottomed out.

Upside for the red metal is likely to come from growing US housing starts, along with greater electronics and auto sales; however, price pressure will come in the form of higher production.

 

With respect to gold it’s important to remember that the decline in price is inversely related to the current strength in the US dollar, and that the price remains strong in terms of most other currencies, which have also weakened against the dollar.

Inevitably, the dollar will overshoot and then be sold off.

The exact timing is of course impossible to predict, but potentially during H2 2015 as growth starts to accelerate outside of the US.

I believe that gold will re-establish its support base around $1,300 per ounce during 2015.

Gavin Wendt is the founder of MineLife, publisher of the MineLife Weekly Resource Report

This article first appeared in The Digger